Live feed
Filing
SC 13G
SC 13G0000902664-15-003515·ADAGE CAPITAL PARTNERS GP, L.L.C.
Schedule 13G ownership disclosure
Cynapsus Therapeutics Inc.
Security class unavailable · CUSIP: 23257Y859
Event date: 2015-08-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 650,000
- Percent of class
- 5.3600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-15-003515
- Form type
- SC 13G
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Aug 28, 2015
- Reporting period
- Aug 20, 2015
- Description
- Schedule 13G beneficial ownership